Literature DB >> 29397298

Detection of respiratory bacterial pathogens causing atypical pneumonia by multiplex Lightmix® RT-PCR.

Karoline Wagner1, Burkard Springer2, Frank Imkamp1, Onya Opota3, Gilbert Greub4, Peter M Keller5.   

Abstract

Pneumonia is a severe infectious disease. In addition to common viruses and bacterial pathogens (e.g. Streptococcus pneumoniae), fastidious respiratory pathogens like Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella spp. can cause severe atypical pneumonia. They do not respond to penicillin derivatives, which may cause failure of antibiotic empirical therapy. The same applies for infections with B. pertussis and B. parapertussis, the cause of pertussis disease, that may present atypically and need to be treated with macrolides. Moreover, these fastidious bacteria are difficult to identify by culture or serology, and therefore often remain undetected. Thus, rapid and accurate identification of bacterial pathogens causing atypical pneumonia is crucial. We performed a retrospective method evaluation study to evaluate the diagnostic performance of the new, commercially available Lightmix® multiplex RT-PCR assay that detects these fastidious bacterial pathogens causing atypical pneumonia. In this retrospective study, 368 clinical respiratory specimens, obtained from patients suffering from atypical pneumonia that have been tested negative for the presence of common agents of pneumonia by culture and viral PCR, were investigated. These clinical specimens have been previously characterized by singleplex RT-PCR assays in our diagnostic laboratory and were used to evaluate the diagnostic performance of the respiratory multiplex Lightmix® RT-PCR. The multiplex RT-PCR displayed a limit of detection between 5 and 10 DNA copies for different in-panel organisms and showed identical performance characteristics with respect to specificity and sensitivity as in-house singleplex RT-PCRs for pathogen detection. The Lightmix® multiplex RT-PCR assay represents a low-cost, time-saving and accurate diagnostic tool with high throughput potential. The time-to-result using an automated DNA extraction device for respiratory specimens followed by multiplex RT-PCR detection was below 4 h, which is expected to significantly improve diagnostics for atypical pneumonia-associated bacterial pathogens.
Copyright © 2018 The Authors. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Keywords:  Atypical pneumonia; High throughput screening; Lightmix(®) kit; Molecular detection; Multiplex RT-PCR; Respiratory pathogens

Mesh:

Substances:

Year:  2018        PMID: 29397298     DOI: 10.1016/j.ijmm.2018.01.010

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  5 in total

1.  Preparation of IgY Oriented Conjugated Fe3O4 MNPs as Immunomagnetic Nanoprobe for Increasing Enrichment Efficiency of Staphylococcus aureus Based on Adjusting the pH of the Solution System.

Authors:  Xuening Shi; Hongbin Sun; Hang Li; Shengnan Wei; Jin Jin; Chao Zhao; Juan Wang; Hui Li
Journal:  Front Public Health       Date:  2022-05-20

2.  Epidemiology of Legionnaires' Disease, Hong Kong, China, 2005-2015.

Authors:  Yiu-Hong Leung; Chau-Kuen Lam; Yung-Yan Cheung; Chi-Wai Chan; Shuk-Kwan Chuang
Journal:  Emerg Infect Dis       Date:  2020-08       Impact factor: 6.883

3.  Frequency and antimicrobial resistance pattern of bacterial isolates from patients with COVID-19 in two hospitals of Zanjan.

Authors:  Narges Moradi; Niloufar Kazemi; Mehdi Ghaemi; Bahman Mirzaei
Journal:  Iran J Microbiol       Date:  2021-12

Review 4.  Community-acquired bacterial pneumonia in adults: An update.

Authors:  Vandana Kalwaje Eshwara; Chiranjay Mukhopadhyay; Jordi Rello
Journal:  Indian J Med Res       Date:  2020-04       Impact factor: 2.375

5.  Development of Multiplex RT-PCR with Immobilized Primers for Identification of Infectious Human Pneumonia Pathogens.

Authors:  S A Lapa; R A Miftakhov; E S Klochikhina; Yu I Ammur; S A Blagodatskikh; V E Shershov; A S Zasedatelev; A V Chudinov
Journal:  Mol Biol       Date:  2021-12-17       Impact factor: 1.374

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.